Clinical trials
Recruiting Graves Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 9 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Zhongshan Hospital | 3 |
| Changchun GeneScience Pharmaceutical Co., Ltd. | 1 |
| First Hospital of China Medical University | 1 |
| Peking Union Medical College Hospital | 1 |
| Shanghai Changzheng Hospital | 1 |
| The First Affiliated Hospital of Xiamen University | 1 |
| The First Affiliated Hospital with Nanjing Medical University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Graves Disease | 9 |
| Cardiovascular Abnormalities | 1 |
| Graves Ophthalmopathy | 1 |
| Neoplasms | 1 |
| Recurrence | 1 |
| Substance Withdrawal Syndrome | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.